Triple and quadruple therapy after renal transplantation in patients from developing countries.
D001379:Azathioprine / Q000627:therapeutic use*; D002102:Cadaver; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003906:Developing Countries; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000191:economics; D007239:Infections / Q000209:etiology; D007674:Kidney Diseases / Q000139:chemically induced; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D014019:Tissue Donors
D003524:Cyclosporins; D005938:Glucocorticoids; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone